China SXT Pharmaceuticals, Inc.

CIK 1723980 · 169 filings in 29 form types · 2017-12-04 to 2026-10-21 · SXTC

FiledFormCategory8-K items / descriptionAccession
2026-10-21 6-K Current reports REPORT OF FOREIGN PRIVATE ISSUER 0001213900-26-111404
2026-10-15 SCHEDULE 13G Ownership 0001493152-26-047269
2026-10-09 6-K Current reports REPORT OF FOREIGN PRIVATE ISSUER 0001213900-26-108557
2026-10-09 424B5 Registrations and prospectuses 0001213900-26-108254
2026-10-08 6-K Current reports REPORT OF FOREIGN PRIVATE ISSUER 0001213900-26-107829
2026-10-08 6-K Current reports REPORT OF FOREIGN PRIVATE ISSUER 0001213900-26-107719
2026-09-16 EFFECT Registrations and prospectuses 9999999995-26-002978
2026-08-28 F-3/A Registrations and prospectuses 0001213900-26-095149
2026-08-28 6-K Current reports REPORT OF FOREIGN PRIVATE ISSUER 0001213900-26-095147
2026-07-24 6-K Current reports REPORT OF FOREIGN PRIVATE ISSUER 0001213900-26-081405
2026-07-24 424B5 Registrations and prospectuses 0001213900-26-081135
2026-07-07 F-3 Registrations and prospectuses 0001213900-26-075977
2026-07-06 6-K Current reports REPORT OF FOREIGN PRIVATE ISSUER 0001213900-26-075528
2026-07-01 20-F Financial reports ANNUAL REPORT 0001213900-26-074310
2026-06-01 6-K Current reports REPORT OF FOREIGN PRIVATE ISSUER 0001213900-26-063591
2026-06-01 424B5 Registrations and prospectuses 0001213900-26-063590
2026-05-04 6-K Current reports REPORT OF FOREIGN PRIVATE ISSUER 0001213900-26-051679
2026-04-27 3 Ownership 0001213900-26-048007
2026-04-27 3 Ownership 0001213900-26-048006
2026-04-27 3 Ownership 0001213900-26-048005
2026-04-27 3 Ownership 0001213900-26-048003
2026-04-27 3 Ownership 0001213900-26-048001
2026-04-27 3 Ownership 0001213900-26-048000
2026-04-27 3 Ownership 0001213900-26-047998
2026-04-09 424B5 Registrations and prospectuses 0001213900-26-041766
2026-04-09 6-K Current reports REPORT OF FOREIGN PRIVATE ISSUER 0001213900-26-041765
2026-01-13 6-K Current reports REPORT OF FOREIGN PRIVATE ISSUER 0001213900-26-003910
2026-01-12 424B5 Registrations and prospectuses 0001213900-26-003205
2025-12-31 6-K Current reports REPORT OF FOREIGN PRIVATE ISSUER 0001213900-25-127097
2025-11-14 EFFECT Registrations and prospectuses 9999999995-25-003288
2025-11-10 F-3 Registrations and prospectuses 0001213900-25-108285
2025-11-10 POS AM Registrations and prospectuses 0001213900-25-108213
2025-08-07 SCHEDULE 13G Ownership 0001213900-25-072841
2025-08-07 SCHEDULE 13G Ownership 0001213900-25-072838
2025-08-07 SCHEDULE 13G Ownership 0001213900-25-072835
2025-08-07 SCHEDULE 13G Ownership 0001213900-25-072832
2025-07-31 20-F Financial reports ANNUAL REPORT 0001213900-25-069688
2025-07-29 6-K Current reports REPORT OF FOREIGN PRIVATE ISSUER 0001213900-25-068429
2025-07-15 6-K Current reports CURRENT REPORT 0001213900-25-064149
2025-06-16 6-K Current reports REPORT OF FOREIGN PRIVATE ISSUER 0001213900-25-054611
2025-05-19 424B5 Registrations and prospectuses 0001213900-25-045088
2025-05-13 6-K Current reports REPORT OF FOREIGN PRIVATE ISSUER 0001213900-25-042394
2025-05-07 424B5 Registrations and prospectuses 0001213900-25-040407
2025-03-28 S-8 Registrations and prospectuses 0001013762-25-003930
2025-03-28 6-K Current reports REPORT OF FOREIGN PRIVATE ISSUER 0001013762-25-003583
2025-03-19 6-K Current reports REPORT OF FOREIGN PRIVATE ISSUER 0001213900-25-024830
2025-01-27 6-K Current reports REPORT OF FOREIGN PRIVATE ISSUER 0001213900-25-006976
2025-01-23 6-K Current reports REPORT OF FOREIGN PRIVATE ISSUER 0001213900-25-005977
2025-01-21 SCHEDULE 13G/A Ownership 0001851416-25-000004
2024-11-04 EFFECT Registrations and prospectuses 9999999995-24-003364